Makoschey B, Sonnemans D, Bielsa J Muñoz, Franken P, Mars M, Santos L, Alvarez M
Intervet International, Wim de Körverstraat 35, 5831 AN Boxmeer, The Netherlands.
Vaccine. 2007 Aug 10;25(32):6140-5. doi: 10.1016/j.vaccine.2007.01.110. Epub 2007 Feb 16.
In order to evaluate whether cattle vaccinated with an inactivated vaccine against bovine viral diarrhoea virus (BVDV) can be differentiated serologically from BVDV infected animals, two different aspects were investigated. Firstly the antibody response against non-structural proteins (NS) was measured after multiple vaccinations of cattle with a single or double dose of a commercially available inactivated BVDV vaccine. In a second study, the animals were first vaccinated with the product, and then infected with BVDV. The antibody response was determined in four different commercial ELISA systems. It can be concluded, that the inactivated BVD vaccine exhibits properties of a marker vaccine when an appropriate antibody NS3 ELISA is applied: after vaccination NS3-specific antibody levels are low or undetectable, but the vaccination does in the present study not show any interference with the development of antibodies against NS3 after subsequent field virus infection.
为了评估接种牛病毒性腹泻病毒(BVDV)灭活疫苗的牛是否能在血清学上与感染BVDV的动物区分开来,研究了两个不同方面。首先,在用单剂量或双剂量市售BVDV灭活疫苗多次接种牛后,测定其针对非结构蛋白(NS)的抗体反应。在第二项研究中,动物先接种该产品,然后感染BVDV。在四种不同的商业ELISA系统中测定抗体反应。可以得出结论,当应用适当的NS3抗体ELISA时,灭活的BVD疫苗表现出标记疫苗的特性:接种疫苗后,NS3特异性抗体水平较低或无法检测到,但在本研究中,接种疫苗并未显示对随后田间病毒感染后针对NS3的抗体产生有任何干扰。